Drug Trial Radar · NCT03078478
A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
Last checked: Nov 20, 2026Latest source record: Jan 11, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,609
Actual
Start
Mar 13, 2017
Primary completion
Feb 13, 2019
Study completion Mar 4, 2019
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Mar 13, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is conducted in Europe and North America. The aim of the trial is to compare the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without oral antidiabetic drugs. Due to change in glycaemic data collection process, this trial is amended to allow for a full 36 weeks (maintenance 2 period) of the use of the new process.
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
Insulin degludecDrug
For subcutaneous (s.c., under the skin) injection once daily
Insulin glargineDrug
For subcutaneous (s.c., under the skin) injection once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Severe or BG-confirmed Symptomatic Hypoglycaemic Episodes During Maintenance 2 (36 Weeks)Time frame: 36 Weeks
Locations
229 sites in 12 countries. Site status is shown where the registry gives one.
Novo Nordisk Investigational Site
Anniston, Alabama
Novo Nordisk Investigational Site
Birmingham, Alabama
Novo Nordisk Investigational Site
Chandler, Arizona
Novo Nordisk Investigational Site
Fountain Hills, Arizona
Novo Nordisk Investigational Site
Glendale, Arizona
Novo Nordisk Investigational Site
Glendale, Arizona
Novo Nordisk Investigational Site
Glendale, Arizona
Novo Nordisk Investigational Site
Phoenix, Arizona
Novo Nordisk Investigational Site
Tucson, Arizona
Novo Nordisk Investigational Site
Buena Park, California
Novo Nordisk Investigational Site
Concord, California
Novo Nordisk Investigational Site
Downey, California
Novo Nordisk Investigational Site
Duarte, California
Novo Nordisk Investigational Site
Fresno, California
Novo Nordisk Investigational Site
La Jolla, California
Novo Nordisk Investigational Site
Lancaster, California
Novo Nordisk Investigational Site
Lomita, California
Novo Nordisk Investigational Site
Los Alamitos, California
Novo Nordisk Investigational Site
Los Angeles, California
Novo Nordisk Investigational Site
Moreno Valley, California
Novo Nordisk Investigational Site
Northridge, California
Novo Nordisk Investigational Site
Palm Springs, California
Novo Nordisk Investigational Site
Pomona, California
Novo Nordisk Investigational Site
Poway, California
Novo Nordisk Investigational Site
Riverside, California
Novo Nordisk Investigational Site
Roseville, California
Novo Nordisk Investigational Site
Sacramento, California
Novo Nordisk Investigational Site
San Mateo, California
Novo Nordisk Investigational Site
San Ramon, California
Novo Nordisk Investigational Site
Stanford, California
Novo Nordisk Investigational Site
Vista, California
Novo Nordisk Investigational Site
Walnut Creek, California
Novo Nordisk Investigational Site
West Hills, California
Novo Nordisk Investigational Site
Colorado Springs, Colorado
Novo Nordisk Investigational Site
Englewood, Colorado
Novo Nordisk Investigational Site
Waterbury, Connecticut
Novo Nordisk Investigational Site
Bradenton, Florida
Novo Nordisk Investigational Site
Brandon, Florida
Novo Nordisk Investigational Site
Clearwater, Florida
Novo Nordisk Investigational Site
Cooper City, Florida
Showing 40 of 229 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.